ＢＴＫ阻害活性を有するピリミジン及びピリジン化合物を用いた癌の治療方法 - Merck Patent Gesellschaft mit beschraenkter Haftung

Title:

ＢＴＫ阻害活性を有するピリミジン及びピリジン化合物を用いた癌の治療方法

Document Type and Number:

Japanese Patent JP6913100

Kind Code:

B2

Abstract:

The invention provides pyrimidine compounds A225 and A250, which are inhibitors of Bruton's tyrosine kinase (BTK), for use in treating cancer.

More Like This:

JP2008543855	Methods and Compositions for Treating Osteoarthritis
WO/2003/099817	8-FLUORIMIDAZO&grave 1,2-A!PYRIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS
JP7379094	External liquid

Inventors:

Bayyard Earl Hack
Samantha M. Goodstal
Claude Gimi-Makkim

Application Number:

JP2018543055A

Publication Date:

August 04, 2021

Filing Date:

November 04, 2016

Export Citation:

Assignee:

Merck Patent Gesellschaft mit beschraenkter Haftung

International Classes:

A61K31/506; A61P35/02; A61P43/00

Domestic Patent References:

JP2014517016A

Foreign References:

US20140275012
WO2015140566A1

Attorney, Agent or Firm:

Atsushi Aoki
Shinji Mitsuhashi
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei
Hidena Tsuda

Previous Patent: 信頼入力を伴うデジタルフィルタ

Next Patent: 放射性標識大環状ＥＧＦＲ阻害剤